Tempus AI to present breast cancer treatment prediction study at 2026 SABCS
TEM•Tempus AI will present 16 abstracts at the San Antonio Breast Cancer Symposium, scheduled for Dec. 8-11, 2026. Late-breaking data on Dec. 10 will highlight an AI model's potential to identify outcome differences and treatment benefits in metastatic breast cancer.
1. Symposium presentations
Tempus AI will present 16 abstracts at the San Antonio Breast Cancer Symposium. Late-breaking data on Dec. 10 will highlight an AI model's potential to identify outcome differences and treatment benefits in metastatic breast cancer.
2. HER2 RNA study
A separate study found HER2 RNA outperformed immunohistochemistry in predicting outcomes with trastuzumab deruxtecan; its results will be presented Dec. 9.




